TI
ONCE

Telemetry Investments’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Telemetry Investments’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-4,100
Closed -$467K – 118
2019
Q1 		$467K Buy
+4,100
New +$301K 0.24% 55

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Telemetry Investments's ONCE Position: Q2 2019 in Review

Telemetry Investments sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2019, closing a stake of 4,100 shares — an estimated $467K sold.

Telemetry Investments first reported a position in ONCE in Q1 2019 and held it in 1 quarter. The position peaked at $467K in Q1 2019. 194 funds tracked by Wall St. Rank hold ONCE as of Q2 2019.

  • Telemetry Investments reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Telemetry Investments sold 4,100 Spark Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $467K.
  • Telemetry Investments first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • Telemetry Investments's Spark Therapeutics, Inc. Common Stock position peaked at $467K in Q1 2019.
  • 194 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Telemetry Investments's 13F filing for Q2 2019, filed 14 Aug 2019.